Dr. Ekholm-Reed received a B.A. in Biochemistry from the University of Lund and a PhD in Cancer Biology from the Karolinska Institute in Stockholm, Sweden, in 2004. Her thesis focused on the role of cyclin E and SCF Fbw7 , the E3 ligase that targets cyclin E for degradation, in the context of cell cycle progression and cancer. This work, which was continued during post-doctoral studies in Steven Reed’s laboratory at the Scripps Research Institute, was central to the identification of a therapeutic target for treatment of chronic myelogenous leukemia, which is the basis for Xtem’s technology. Subsequently she has been a key person involved in developing and testing therapeutic molecules in our drug discovery program.
Dr. Susanna Ekholm-Reed, Ph.D.